Secondary
Albireo Pharma, Inc.
Albireo Pharma is a clinical-stage biopharmaceutical company focused through its operating subsidiary on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders.
Symbol
ALBO
Last Closing Price
$35.76
Effective Date
January 25, 2018
Underwriters
Cowen & Co., William Blair
To view the prospectus for Albireo Pharma, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277